Publications by authors named "Jason D Thorpe"

Claim this Profile
V
Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded study.
Jing Wu, Haidi Yin, Jianhui Zhu, Ronald J Buckanovich, Jason D Thorpe

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.
Chris P Miller, Jason D Thorpe, Amanda N Kortum, Catherine M Coy, Wei-Yi Cheng

Cancer Immunol Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.
Charles W Drescher, Sarah Hawley, Jason D Thorpe, Simone Marticke, Martin McIntosh

Cancer Prev Res (Phila)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role of HE4 in multimodal screening for epithelial ovarian cancer.
Nicole Urban, Jason D Thorpe, Lindsay A Bergan, Robin M Forrest, Archana V Kampani

J Natl Cancer Inst· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irradiation effect after mastectomy on breast cancer recurrence in patients presenting with locally advanced disease.
Angie R Taras, Jason D Thorpe, Astrid D Morris, Mary Atwood, Kimberly A Lowe

Am J Surg· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.
Garnet L Anderson, Martin McIntosh, Lieling Wu, Matt Barnett, Gary Goodman, Jason D Thorpe

J Natl Cancer Inst· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.
Sharon J Pitteri, Lellean JeBailey, Vitor M Faça, Jason D Thorpe, Melissa A Silva

PLoS One· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.
Chirag A Shah, Kimberly A Lowe, Pamela Paley, Erin Wallace, Garnet L Anderson, Jason D Thorpe

Cancer Epidemiol Biomarkers Prev· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic evaluation of candidate blood markers for detecting ovarian cancer.
Chana Palmer, Xiaobo Duan, Sarah Hawley, Nathalie Scholler, Jason D Thorpe

PLoS One· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.
Nathalie Scholler, Kimberly A Lowe, Lindsay A Bergan, Archana V Kampani, Vivian Ng, Jason D Thorpe

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of blood collection conditions on ovarian cancer serum markers.
Jason D Thorpe, Xiaobo Duan, Robin Forrest, Kimberly Lowe, Lauren Brown

PLoS One· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis